Ocular Surface

The Ocular Surface publishes clinical and basic research on the ocular surface and tear film, was founded in 2003 and is published by Elsevier, with a 2025 Journal Impact Factor of 6.6《眼表》（Ocular Surface）发表眼表与泪膜方面的临床与基础研究，2003 年创办，由（Elsevier）出版，2025 年影响因子为 6.6

Scope

• The journal covers the ocular surface and tear film该刊覆盖眼表与泪膜
• Dry eye disease and ocular surface inflammation are central subjects干眼病与眼表炎症是核心主题
• Corneal and conjunctival biology are covered角膜与结膜生物学在其范围
• Contact lens complications and ocular surface surgery are within scope接触镜并发症与眼表手术同样收录
• Ocular surface imaging and diagnostic techniques are published眼表成像与诊断技术均在发表之列
• Clinical trials of ocular surface therapies are welcomed眼表治疗的临床试验受到欢迎

History

• The journal was founded in 2003 as a specialised outlet for ocular surface science该刊 2003 年创办，是眼表科学的专业刊物
• It serves the community around the tear film and ocular surface research society期刊服务于泪膜与眼表研究学界
• Elsevier publishes the journal today期刊现由（Elsevier）出版
• The journal is published by Elsevier and appears quarterly, under print ISSN 1542-0124, electronic ISSN 1937-5913该刊由（Elsevier）出版，按季刊出版，印刷 ISSN 为 1542-0124，电子 ISSN 为 1937-5913。-
• Its Journal Impact Factor was 5.033 in 2021 and reached 6.6 in 2025, with the reported series 6.6, 5.6, 6.268, 5.033其影响因子由 2025 年的 6.6、2024 年的 5.6、2022 年的 6.268、2021 年的 5.033 等年度数据构成，最新为 2025 年的 6.6。

Editors

• An editor-in-chief is supported by associate editors across clinical and basic ocular surface work主编由覆盖眼表临床与基础方向的副编辑协助
• The journal publishes original research, reviews and consensus reports期刊发表原创研究、综述与共识报告
• Papers linking tear film biochemistry to clinical outcomes are encouraged鼓励把泪膜生物化学与临床结局相联系的论文
• It is indexed in the Science Citation Index Expanded, MEDLINE, Scopus and PubMed该刊被（Science Citation Index Expanded）、（MEDLINE）、（Scopus）与（PubMed）收录。